Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines

PLoS ONE - United States
doi 10.1371/journal.pone.0040900
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Distinct P53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers

Clinical Cancer Research
Cancer ResearchOncology
2011English

Estrogen Receptor (ER) mRNA Expression and Molecular Subtype Distribution in ER-negative/progesterone Receptor-Positive Breast Cancers

Breast Cancer Research and Treatment
Cancer ResearchOncology
2013English

Genetically Engineered ER -Positive Breast Cancer Mouse Models

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2014English

Glucocorticoid Receptor Modulation Decreases ER-positive Breast Cancer Cell Proliferation and Suppresses Wild-Type and Mutant ER Chromatin Association

Breast Cancer Research
Cancer ResearchOncology
2019English

Prohibitin Promotes Androgen Receptor Activation in ER-positive Breast Cancer

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2017English

ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells

PLoS ONE
Multidisciplinary
2014English

Estrogen Therapy Induces an Unfolded Protein Response to Drive Cell Death in ER + Breast Cancer

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Identification of Potential Glycoprotein Biomarkers in Estrogen Receptor Positive (ER+) and Negative (ER-) Human Breast Cancer Tissues by LC-LTQ/FT-ICR Mass Spectrometry

Journal of Cancer
Oncology
2012English

Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy